NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy

Mireille Jacobson, Tom Y. Chang, Joseph P. Newhouse, Craig C. Earle, M.D.

NBER Working Paper No. 19247
Issued in July 2013
NBER Program(s):   HC

We investigate the role of physician agency and competition in determining health care supply and patient outcomes. A 2005 change to Medicare fees had a large, negative impact on physician profit margins for providing chemotherapy treatment. In response to these cuts, physicians increased their provision of chemotherapy and changed the mix of chemotherapy drugs they administered. The increase in treatment improved patient survival. These changes were larger in states that experienced larger decreases in physician profit margins. Finally while physician response was larger in more competitive markets, survival improvements were larger in less competitive markets.

download in pdf format
   (1828 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w19247

Users who downloaded this paper also downloaded* these:
Johnson and Rehavi w19242 Physicians Treating Physicians: Information and Incentives in Childbirth
Clemens and Gottlieb w19503 In the Shadow of a Giant: Medicare's Influence on Private Physician Payments
Rebitzer and Votruba w17535 Organizational Economics and Physician Practices
Chandra, Holmes, and Skinner w19700 Is This Time Different? The Slowdown in Healthcare Spending
Howard, Bach, Berndt, and Conti w20867 Pricing in the Market for Anticancer Drugs
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us